Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study

Virchows Archiv

Volumn 430, Issue 6, 1997, Pages 461-466

  Chow, Nan Haw ^a   Liu, Hsiao Sheng ^b   Yang, Hsiao Bai ^a   Chan, Shih Huang ^b   Su, Ih Jen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Carcinogenesis; Differentiation; erbB receptor family; Urothelium

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN TYROSINE KINASE;

ARTICLE; CANCER GRADING; CANCER INVASION; CARCINOGENESIS; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C ERB; ONCOGENE NEU; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, EPIDERMAL GROWTH FACTOR; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0030818275     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050056     Document Type: Article

References (30)

1. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fore PP, Kraus MH (1995) Cooperative signaling of ErbB3 und ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10:1813-1821
2. Boer WI de, Schuller AGP, Vermey M, Kwast TH van der (1994) Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am J Pathol 145:1199-1207
3. Carraway KL III, Cantley LC (1994) A new acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling. Cell 78:5-8
4. Carraway KL, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A, Diamonti AJ, Vandlen RL, Cantley LC, Cerione RA (1994) The erbB3 gene product is a receptor for heregulin. J Biol Chem 269:14303-14306
5. Chow NH, Tzai TS, Cheng PE, Chang CJ, Lin SN, Tang MJ (1994) An assessment of immunoreactive epidermal growth factor in urine of patients with urological diseases. Urol Res 22:221-225
6. Gasparini G, Pozza F, Meli S, Reitano M, Santini G, Bevilaxqua P (1991) Breast cancer cell kinetics: immunocytochemical determination of growth tractions by nomoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness. Anticancer Res 11:2015-2021
7. Gullick WJ, Berger MS, Bennett PLP, Rothbard JB, Waterfield MD (1987) Expression of the c-erbB-2 protein in normal and transformed cells. Int J Cancer 40:246-254
8. Jochum W, Schroder S, Al-Taha R, August C, Gross AJ, Berger J, Padberg BC (1996) Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry. Cancer 77:514-521
9. Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ (1991) Association of c-erbB-2 protein overexpression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 49:650-655
10. Kim HH, Sierke SL, Koland JG (1994) Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. J Biol Chem 269:24747-24755
11. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA (1989) Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86:9193-9197
12. Lee SE, Chow NH, Chi YC, Tzai TS, Yang WH, Lin SN (1994) Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer. Anticancer Res 14:1317-1324
13. Lipponen P (1993) Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer. Eur J Cancer [A] 29:749-753
14. Messing EM (1990) Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 50:2530-2537
15. Neal DE, Sharples, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619-1625
16. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbick JR, Riethmuller G (1993) Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85: 1419-1424
17. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, Di Fiore PP, Aaronson SA (1991) Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene 6: 1189-1194
18. Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG, Shoyab M (1993) Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90:1746-1750
19. Press MF, Cordon-Cardo C, Slamon DJ (1990) Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5:953-962
20. Prigent SA, Lemoine NR, Hughes CM, Plowman GD, Selden C, Gullick WJ (1992) Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene 7:1273-1278
21. Pusztai L, Lewis CE, Lorenzen J, McGee J (1993) Growth factors: regulation of normal and neoplastic growth. J Pathol (Lond) 169:191-201
22. Rebel JM, Boer WI de, Thijssen CD, Vermey M, Zwarthoff EC, Kwast TH van der (1994) An in vitro model of urothelial regeneration: effects of growth factors and extracellular matrix proteins. J Pathol (Lond) 173:283-291
23. Singleton TP, Niehans GA, Gu F, Litz, CE, Hagen K, Qiu Q, Kiang DT, Strickler JG (1992) Detection of c-erbB-2 activation in paraffin-embedded tissue by immunohistochemistry. Hum Pathol 23:1141-1150
24. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin R (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:2237-2241
25. Sliwkowsk MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269:14661-14665
26. Soltoff SP, Carraway KL, Prigent SA, Gullick WG, Cantley LC (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol 14: 3550-3558
27. Tsutsumi Y, Naber SP, De Lellis RA, Wolfe HJ, Marks PJ, McKenzie SJ, Yin S (1990) Neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues. Hum Pathol 21:750-758
28. Wagner U, Sauter G, Moch H, Novotna H, Epper R, Mihatsch MJ, Waldman FM (1995) Patterns of p53, erbB-2, EGF-r expression in premalignant lesions of the urinary bladder. Hum Pathol 26:970-978
29. Wang DP Jr, Fujii S, Konishi I, Nanbu Y, Iwai T, Nonogaki H, Mori T (1992) Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta. Virchows Arch [A] 420:385-393
30. Weidner U, Peters S, Strohmeyer T, Hussnaetter R, Ackerman R, Sies H (1990) Inverse relationship of epidermal growth factor receptor and HER-2/neu gene expression in human renal cell carcinoma. Cancer Res 50:4504-4509